We are the oldest pharmaceutical and chemical company in the world. Our roots date back to the year 1668.
In order to share and document the company's history, we offer access to external visitors and researchers to the following resources at the site premises:
Archive and historical library
Sources include about 2,000 meters of hand-written and printed archive material, such as letters, contracts, patents, laboratory journals, manufacturing specifications and advertisements. The oldest documents are about 400 years old. There are over 150,000 photos and films illustrating the last 150 years of corporate history.
The reference library contains more than 8,000 books and an extensive collection of journals. There is an extremely wide variety of topics, ranging from recipe and herb books of the 15th century to expert literature on corporate strategy of the 21st century.
Museum and event rooms
The museum, which features a well-stocked exhibition, the history of the company is presented as a precondition for today's success. It makes day-to-day activities in a company understandable – starting with the work in the pharmacy and industrial research, production and administration all the way to company sports, the cafeteria or the daycare center.
In addition, rooms are available for lectures small symposia and educational museum events.
||Friedrich Jacob Merck acquires the Angel Pharmacy ("Engel-Apotheke")
||Johann Heinrich Merck, Goethe's friend, is born
||Emanuel Merck: from a pharmacy trade to a research-based industrial company
||Comparative chemical analysis with "guaranteed pure reagents"
||The company is represented on all continents
||First list of finished medicinal products; Substances with liquid crystalline properties available
||U.S. subsidiary Merck & Co. expropriated - independent ever since
||For the first time, non-family members join the executive management
||Loss of subsidiaries abroad, in Darmstadt new start from the ruins
||Firm re-establishement in the United States – after Asia and Latin America
||Establishment of Merck KGaA, Darmstadt, Germany, public listing
||Erbitux®: Entry into targeted cancer therapy
||Serono acquisition, divestment of Generics, capital increase, admission to the DAX®